SCHEMBL7363404

SCHEMBL7363404

CC(C)(C)OC(=O)CCNC(=O)c1ccc2c(NC(N)=NCl)cncc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 1/20 0.41
CSNK2A2 P19784 2/20 0.36
CSNK2B P67870 2/20 0.36
CSNK2A1 P68400 2/20 0.36
CSNK2A3 Q8NEV1 2/20 0.36
CLK2 P49760 1/20 0.36
NAMPT P43490 2/20 0.35
PTPRC P08575 2/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MLYCD O95822 1/20 0.34
CYP17A1 P05093 1/20 0.33
CYP3A4 P08684 1/20 0.33
PI4KA P42356 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367816 0.92 PTPRC (0.42) DGAT2NAMPTPTPRCMAPTCYP17A1
SCHEMBL7378246 0.86 CA1 (0.42) CSNK2A2CSNK2BCSNK2A1CSNK2A3NR1H4
SCHEMBL7367638 0.82 S1PR1 (0.40) PDK1PDK2PDK3PDK4
SCHEMBL6433843 0.80 DGAT2 (0.41) DGAT2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL7050306 0.76 PLAU (0.37) MAPTSMN1; SMN2NPC1RAB9APDK1
SCHEMBL7375649 0.76 NR1D1 (0.35) MAPTPDK1PDK2PDK3PDK4
SCHEMBL7050066 0.75 PLAU (0.39) MAPTSMN1; SMN2CYP3A4KMT2A
SCHEMBL7368535 0.74 NR1D1 (0.35)
SCHEMBL7370338 0.72 PLAU (0.34)
SCHEMBL6433846 0.72 DGAT2 (0.47) DGAT2CSNK2A2CSNK2BCSNK2A1CSNK2A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242120-A2 COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE Pfizer Limited (GB) 2002-09-25 EP disclosed
WO-2001049309-A2 COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE PFIZER LIMITED (GB) 2001-07-12 WO disclosed
EP-1077945-A1 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2001-02-28 EP disclosed
WO-2000005214-A2 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2000-02-03 WO disclosed